The Malaria Vaccine (MalVax) Alliance
Accelerating the development of better vaccines for a malaria free future.
INTRODUCING MALVAX
The Malaria Vaccine (MalVax) Alliance is a new global, independent collaboration accelerating the development of malaria vaccines.
The MalVax Alliance unites the malaria vaccine R&D community to drive evidence and innovation from lab to policy faster, so better vaccines reach the people who need them sooner. It coordinates action around shared priorities by:
Strengthening innovation and clinical investigation through shared frameworks
Improving the quality and comparability of research evidence
Accelerating the translation of that evidence into regulatory and policy decisions
Objectives
Together, we are working to:

Share Science
Strengthen scientific exchange and shared knowledge across the community.

Break Bottlenecks
Coordinate expertise to address common research and development challenges.

Align Efforts
Improve comparability and support evidence generation across the ecosystem.
MalVax 2027: The First Global Malaria Vaccine Alliance R&D Conference
Latest News
Stay up to date with the latest developments from MalVax Alliance.
Working Groups

We are pleased to announce the Working Group Co-Chairs have now been confirmed and are actively setting up and organising their groups to address the most pressing barriers to next-generation malaria vaccine R&D. Planning is underway to create opportunities for community consultation beyond Working Group members to ensure you all have a chance to feed into this important work. Interactive sessions with the Working Groups will also be included on the MalVax 2027 conference programme.
You can find out more about our Working Groups here
Conference

The conference will take place in Kuala Lumpur, 31 January to 3 February 2027 at the Shangri-La Hotel. A discounted room block has been arranged at the venue for conference participants. Click here for more information and to reserve your room.
MalVax Alliance

The Executive Committee and Support Unit continue to establish MalVax, including Working Groups, governance structures, and community engagement activities.
Get involved
Stay Informed about MalVax
The success of the MalVax Alliance depends on the strength of its community. Whether you are a researcher, clinician, laboratory scientist, vaccine developer, modeller, policymaker, regulator, funder, or implementation partner, we invite you to be part of this collaborative effort to accelerate the development of next-generation malaria vaccines.
If you have not done so yet, please complete our engagement form using the link below to receive updates about the MalVax Alliance and the MalVax 2027 conference.
Contact Us
For questions about MalVax, visit our FAQs.
For any additional questions, please contact the Support Unit at Bridges to Development.
Social Media
We encourage interested partners to follow us on social media and use the following hashtags:
#MalVaxAlliance #MalVax2027
FUNDER
Coefficient Giving
The establishment of the MalVax Alliance and the initiation of the inaugural conference has been made possible thanks to support from Coefficient Giving.